Francois Rochon’s Novo Nordisk NVO Stock Holding History

Francois Rochon’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,400	Closed	-$456K	–	54
2026 Q1	$456K	Hold	12,400	–	–	0.02%	51
2025 Q4	$631K	Hold	12,400	–	–	0.02%	46
2025 Q3	$688K	Hold	12,400	–	–	0.02%	50
2025 Q2	$856K	Hold	12,400	–	–	0.03%	49
2025 Q1	$861K	Hold	12,400	–	–	0.03%	49
2024 Q4	$1.07M	Hold	12,400	–	–	0.04%	49
2024 Q3	$1.48M	Hold	12,400	–	–	0.06%	43
2024 Q2	$1.77M	Hold	12,400	–	–	0.07%	40
2024 Q1	$1.59M	Hold	12,400	–	–	0.06%	41
2023 Q4	$1.28M	Hold	12,400	–	–	0.06%	44
2023 Q3	$1.13M	Hold	12,400	–	–	0.06%	42
2023 Q2	$1M	Hold	12,400	–	–	0.05%	43
2023 Q1	$987K	Hold	12,400	–	–	0.06%	43
2022 Q4	$839K	Hold	12,400	–	–	0.05%	46
2022 Q3	$618K	Hold	12,400	–	–	0.04%	45
2022 Q2	$691K	Hold	12,400	–	–	0.05%	45
2022 Q1	$689K	Hold	12,400	–	–	0.04%	47
2021 Q4	$694K	Hold	12,400	–	–	0.04%	54
2021 Q3	$595K	Hold	12,400	–	–	0.04%	49
2021 Q2	$519K	Hold	12,400	–	–	0.03%	47
2021 Q1	$418K	Hold	12,400	–	–	0.03%	47
2020 Q4	$433K	Hold	12,400	–	–	0.03%	47
2020 Q3	$430K	Buy	+12,400	New	+$413K	0.04%	47

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Francois Rochon's NVO Position: Q2 2026 in Review

Francois Rochon sold out of Novo Nordisk (NVO) in Q2 2026, closing a stake of 12,400 shares — an estimated $456K sold.

Francois Rochon first reported a position in NVO in Q3 2020 and held it in 23 quarters. The position peaked at $1.77M in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Francois Rochon reported no remaining Novo Nordisk position as of Q2 2026 after selling out during the quarter.
Francois Rochon sold 12,400 Novo Nordisk shares in Q2 2026, an estimated $456K.
Francois Rochon first reported a position in Novo Nordisk in Q3 2020 and held it in 23 quarters.
Francois Rochon's Novo Nordisk position peaked at $1.77M in Q2 2024.
1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Giverny Capital's 13F filing for Q2 2026, filed 14 Aug 2026.